A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy Volunteers
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This open-label, two-period, fixed-sequence study will investigate the pharmacokinetics and
safety of multiple doses of aleglitazar on a single dose of digoxin in healthy volunteers. In
period 1, volunteers will receive a single dose of digoxin, in period 2 volunteers will
receive multiple doses of aleglitazar and a single dose of digoxin. The anticipated time on
study treatment is one month.